Taken together, these data clearly indicate that experimental diabetes limits CB-ECFC pro-angiogenic capacity, whilst suggesting that loss of NOX4 signalling may be pivotal in mediating the observed lack of migratory and tubulogenic response. The gene discussed is NOX4; the disease is diabetes mellitus.